Anemias Completed Phase 2 Trials for Ruxolitinib (DB08877)

Also known as: Anemia / Anaemia / Anaemia, unspecified / Unspecified anaemia / Unspecified anemia / Anemia, unspecified / Anaemia NOS

IndicationStatusPhase
DBCOND0031070 (Anemias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01732445Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With MyelofibrosisSupportive Care